Compounds / Other / Melanotan II

Melanotan II

Melanotan II (Non-Selective MC1R/MC3R/MC4R Agonist)
OtherWell ResearchedFDA: Not approved (research compound only)

Overview

Research compound only. Tanning research, erectile dysfunction, appetite suppression. Higher side effect profile than selective analogs: nausea, flushing, spontaneous erections.

Mechanism of Action

Non-selective MC1R/MC3R/MC4R agonist. MC1R: melanogenesis (tanning). MC4R: sexual arousal, appetite suppression, erectile activity. More potent but less selective than PT-141 or Melanotan I.

Pharmacokinetics

Half-life
1 hr
Peak (Tmax)
30 min
Cleared
~5 hrs

Molecular Profile

Molecular weight
1024.2 Da
CAS number
121062-08-6

Key Research Findings

Tanning via MC1R; aphrodisiac via MC4R; appetite suppression; higher side effects than selective analogs.

Published Research

Peptides (2006)
Hadley ME, Dorr RT. Melanocortin peptide therapeutics: milestones and commercialization
View source

Related Other Compounds

PT-141Melanotan IPNC-27CystagenDermorphinEPO
Clinical Guidance

Research data is not a treatment plan. If you are considering Melanotan II, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.
Running Melanotan II? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator  ·  Full deep dive  ·  Peptide fundamentals